Loading clinical trials...
Loading clinical trials...
Electrophysiological and Echocardiographic PREDICTors of Atrial Fibrillation Following Interventional Closure of Patent Foramen Ovale in Cryptogenic Stroke: PREDICT-AF-PFO
Conditions
Interventions
PFO closure
Locations
1
Germany
Universitätsklinikum des Saarlandes
Homburg, Saarland, Germany
Start Date
January 15, 2020
Primary Completion Date
June 1, 2021
Completion Date
June 1, 2022
Last Updated
May 24, 2021
NCT04528511
NCT07172464
NCT07420400
NCT06590467
NCT07170176
NCT06203873
Lead Sponsor
University Hospital, Saarland
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions